These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8693517)

  • 21. Human immunodeficiency virus revisited.
    Perkin RL
    Can Fam Physician; 1993 Nov; 39():2507-8. PubMed ID: 8268749
    [No Abstract]   [Full Text] [Related]  

  • 22. World Health Organization. Guidelines for counselling people about Human Immunodeficiency Virus.
    Bayés R
    J Palliat Care; 1998; 14(1):55. PubMed ID: 9575716
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Schmitz JE; Kuroda MJ; Santra S; Sasseville VG; Simon MA; Lifton MA; Racz P; Tenner-Racz K; Dalesandro M; Scallon BJ; Ghrayeb J; Forman MA; Montefiori DC; Rieber EP; Letvin NL; Reimann KA
    Science; 1999 Feb; 283(5403):857-60. PubMed ID: 9933172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory care of patients infected with the human immunodeficiency virus (HIV).
    Trivedi D; Beall G
    Compr Ther; 1989 Jul; 15(7):33-46. PubMed ID: 2670403
    [No Abstract]   [Full Text] [Related]  

  • 25. [The cost of treating human immunodeficiency virus infection: Can reasonably be optimized?].
    Moreno S
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):147-8. PubMed ID: 26803451
    [No Abstract]   [Full Text] [Related]  

  • 26. Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection.
    Montefiori DC; Hill TS; Vo HT; Walker BD; Rosenberg ES
    J Virol; 2001 Nov; 75(21):10200-7. PubMed ID: 11581388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine models for antiretroviral therapy.
    Ruprecht RM
    Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who cares for the human immunodeficiency virus-infected child?
    Oleske JM
    Pediatrics; 1989 Oct; 84(4):727. PubMed ID: 2789365
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
    J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy for HIV Infection.
    Weiss RA
    N Engl J Med; 2014 Jan; 370(4):379-80. PubMed ID: 24450898
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute human immunodeficiency virus infection: false-negative ELISA in a patient with viremia and a positive western blot test.
    Griffith BP; Ferguson D; Mellors JW
    J Infect Dis; 1989 Jul; 160(1):160-1. PubMed ID: 2732510
    [No Abstract]   [Full Text] [Related]  

  • 32. High hydrostatic pressure in cancer immunotherapy and biomedicine.
    Adkins I; Hradilova N; Palata O; Sadilkova L; Palova-Jelinkova L; Spisek R
    Biotechnol Adv; 2018; 36(3):577-582. PubMed ID: 29409785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward rational nutritional support of the human immunodeficiency virus-infected patient.
    Aron JM
    JPEN J Parenter Enteral Nutr; 1991; 15(2):121-2. PubMed ID: 1904946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High hydrostatic pressure processing: a promising nonthermal technology to inactivate viruses in high-risk foods.
    Lou F; Neetoo H; Chen H; Li J
    Annu Rev Food Sci Technol; 2015; 6():389-409. PubMed ID: 25884283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion of the patient with acquired immunodeficiency syndrome.
    Mayer K
    Arch Pathol Lab Med; 1990 Mar; 114(3):295-7. PubMed ID: 2306174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon in AIDS.
    Krown SE; Real FX; Vadhan-Raj S; Oettgen HF
    J Exp Pathol; 1987; 3(4):681-91. PubMed ID: 2457669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obligations to care for persons with human immunodeficiency virus.
    Lo B
    Issues Law Med; 1988; 4(3):367-81. PubMed ID: 3235313
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of children infected with human immunodeficiency virus. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1988 Sep; 139(5):391-2. PubMed ID: 3409118
    [No Abstract]   [Full Text] [Related]  

  • 39. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of high hydrostatic pressure inactivation of Mycobacterium by combination with physical and chemical conditions.
    de Souza AR; da Costa Demonte AL; de Araujo Costa K; Faria MA; Durães-Carvalho R; Lancellotti M; Bonafe CF
    Appl Microbiol Biotechnol; 2013 Aug; 97(16):7417-25. PubMed ID: 23836348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.